Polymer-drug conjugates based on hyaluronic acid for the treatment of rheumatoid arthritis
The work represents an initial appraisal ofhow polymer-drug conjugates based upon hyaluronic acid (HA) may behave at sites of inflammation relative to unmodified HA. Three polymer drug conjugates were synthesized in which a model drug, p-nitroaniline (pNA) has been joined to HA via a peptide spacer...
Main Author: | Singh, Jennifer |
---|---|
Published: |
University of the West of Scotland
2004
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415937 |
Similar Items
-
The development of immunocytokines for the treatment of rheumatoid arthritis
by: Gofur, Yarunnessa
Published: (2005) -
Tolerogenic dendritic cells for the treatment of rheumatoid arthritis
by: Sayers, Bethan Louise
Published: (2008) -
Investigation of Genetic Variation within the TNF Signalling Pathway in Disease Susceptibility and Anti-TNF Treatment Response in Patients With Rheumatoid Arthritis
by: Potter, Catherine
Published: (2007) -
The contribution of the PGDâ‚‚ system to the control of adaptive immune responses with relevance to arthritis
by: Trivedi, Seema Gor
Published: (2005) -
Hyaluronic acid based polymer drug conjugates for the treatment of rheumatoid arthritis
by: Mina, James
Published: (2009)